Evolution of liver transplantation for hepatocellular carcinoma

Journal of Hepatology

Volumn 39, Issue 6, 2003, Pages 888-895

  Adam, René ^a   Del Gaudio, Massimo ^a  

^a HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER SURGERY; COMORBIDITY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; ORGAN DONOR; PRIORITY JOURNAL; RADIOFREQUENCY; SALVAGE THERAPY; SHORT SURVEY; TREATMENT INDICATION; TUMOR DIFFERENTIATION; TUMOR VOLUME;

EID: 0346243793     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2003.10.003     Document Type: Review

References (67)

1. Rustgi VK. Epidemiology of hepatocellular carcinoma. Gastroenterol Clin N Am 1987;16:545-551.
2. El Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-750.
3. Deuffic S, Poynard T, Buffat L, Valleron AJ. Trends in primary liver cancer. Lancet 1998;351:214-215.
4. Kew MC. Epidemiology of hepatocellular carcinoma. Toxicology 2002;27:35-38.
5. Bralet MP, Regimbeau JM, Pineau P, Dubois S, Loas G, Degos F, et al. Hepatocellular carcinoma occurring in non-fibrotic liver: epidemiologic and histopathologic analysis of 80 french cases. Hepatology 2000;32:200-204.
6. Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso MC, Sala M, et al. Natural history of untreated non-surgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutical trials. Hepatology 1999;29:62-67.
7. Mazziotti A, Grazi GL, Cavallari A. Surgical treatment of hepatocellular carcinoma on cirrhosis: a Western experience. Hepatogastroenterology 1998;45:1281-1287.
8. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991;214:114-117.
9. Franco D, Capussotti L, Smadja C, Bouzari H, Meakins J, Kemeny F, et al. Resection of hepatocellular carcinoma. Results in 72 European patients with cirrhosis. Gastroenterology 1990;98:733-738.
10. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999;30:1434-1440.
11. Majno PE, Adam R, Bismuth H, Castaing D, Ariche A, Krissat J, et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997;226:688-701.
12. Livraghi T, Giorgio A, Marin G, Salmi A, De Sio I, Bolondi L, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995;197:101-108.
13. Adam R, Akpinar E, Johann M, Kustlinger F, Majno P, Bismuth H. Place of cryosurgery in the treatment of malignant liver tumours. Ann Surg 1997;225:39-50.
14. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000;214:761-768.
15. Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 1991;15:270-285.
16. Moreno P, Jaurrieta E, Figueras J, Benasco C, Rafecas A, Fabregat J, et al. Orthotopic liver transplantation: treatment of choice in cirrhotic patients with hepatocellular carcinoma? Transplant Proc 1995;27: 2296-2298.
17. European Liver Transplant Registry (ELTR). Updating June 2002. Internet website: www.eltr.org.
18. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993;218:145-151.
19. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.
20. Llovet JM, Bruix J, Fuster J, Castells AG, Garcia-Valdecasas JC, Grande L, et al. Liver transplantation for small hepatocellular carcinoma; the tumour-node-metastases classification does not have prognostic power. Hepatology 1998;27:1572-1577.
21. Iwatsuki S, Gordon RD, Shaw Jr BW, Starzl TE. Role of liver transplantation in cancer therapy. Ann Surg 1985;202:401-407.
22. O'Grady JG, Polson RJ, Rolles K, Calne RY, Williams R. Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg 1988;207:373-379.
23. Figueras J, Jaurrieta E, Valls C, Ramos E, Serrano T, Rafecas A, et al. Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. J Am Coll Surg 2000;190:580-587.
24. Adam R, Azoulay D, Castaing D, Samuel D, Saliba F, Feray C, et al. Long-term results of transplantation for hepatocellular carcinoma with or without cirrhosis: 15 years'-experience at Paul Brousse Hospital. In: Kitajima M, Shimazu M, et al., editors. Current issues in liver and small bowel transplantation, 9. Berlin: Springer; 2001. p. 135-144.
25. Yao FY, Ferrel L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: expansion of tumour size limits dos not adversely impact survival. Hepatology 2001;33:1394-1403.
26. Roayaie S, Frischer J, Emre S, Fishbein T, Sheiner P, Sung M, et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 cm. Ann Surg 2002;235:533-539.
27. Iwatsuki S, Dvorchik I, Marsh JW, Madariaga JR, Carr B, Fung JJ, et al. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 2000;191:389-394.
28. Klintmalm GB. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumour. Ann Surg 1998;228:479-490.
29. Hemming AW, Cattral MS, Reed AI, Van de Werf WJ, Greig PD, Howard RJ. Liver transplantation for hepatocellular carcinoma. Ann Surg 2001;23:652-659.
30. Jonas S, Bechstein WO, Steinmuller T, Hermann M, Radke C, Berg T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001;33:1080-1086.
31. Molmenti EP, Klintmalm GB. Liver transplantation in association with hepatocellular carcinoma: an update of the international tumor registry. Liver Transpl 2002;8:736-748.
32. Takamori R, Wong LL, Dang C, Wong L. Needle-tract implantation from hepatocellular cancer: is needle biopsy of the liver always necessary? Liver Transpl 2000;6:67-72.
33. Trotter JF, Wachs M, Everson GT, Kam I. Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med 2002;346:1074-1082.
34. United Network for Organ Sharing. Annual Report 2000. http://www.unos.org/data.
35. Llovet JM, Mas X, Aponte J, Fuster J, Navasa M, Christensen E, et al. Cost-effectiveness of adjuvant therapy for hepatocellular carcinoma before liver transplantation. Gut 2002;50:123-128.
36. Pereira SP, Williams R. Limits to liver transplantation in UK. Gut 1998;42:883-885.
37. Freeman R, Wiesner R, Harper A, McDiarmid S, Lake J, Edwards E, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002;8:851-858.
38. Lau WY, Leung TW, Ho SK, Chan M, Machin D, Lau J, et al. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. Lancet 1999;353:797-801.
39. Pulvirenti A, Garbagnati F, Regalia E, Coppa J, Marchiano A, Romito R, et al. Experience with radiofrequency ablation of small hepatocellular carcinomas before liver transplantation. Transpl Proc 2001;33:1516-1517.
40. Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000;232:381-391.
41. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002;359:1734-1739.
42. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesaphagus for bleeding oesophageal varices. Br J Surg 1973;60:646-649.
43. Fontana RJ, Hamidullah H, Nghiem H, Greenson JK, Hussain H, Marrero J, et al. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation. Liver Transpl 2002;8:1165-1174.
44. Llovet JM, Vilana R, Bru C, Bianchi L, Salmeron JM, Boix L, et al. Increased risk of tumour seeding after percutaneos radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001;33:1124-1129.
45. Carr B, Selby R, Madriaga J, Iwatsuki S, Starlz TE. Prolonged survival after liver transplantation and cancer chemotherapy for advanced-stage hepatocellular carcinoma. Transpl Proc 1993;25:1128-1129.
46. Cherqui D, Piedbois P, Pierga J-Y, Duvoux C, Vavasseur D, Tran Van-Nhieu J, et al. Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma. Cancer 1994;73:2721-2726.
47. Olthoff KM, Rosove MH, Shackleton CR, Imagawa DK, Farmer DG, Northcross P, et al. Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma. Ann Surg 1995;221:734-743.
48. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002;315:519-524.
49. Regalia E, Coppa J, Pulvirenti A, Romito R, Schiavo M, Burgoa L, et al. Liver transplantation for small hepatocellular carcinoma in cirrhosis: analysis of our experience. Transpl Proc 2001;33:1442-1444.
50. Castells A, Bruix J, Bru C, Ayuso C, Roca M, Boix L, et al. Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients. Gastroenterology 1995;109:917-922.
51. Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996;111:1018-1022.
52. Michel J, Suc B, Montpeyroux F, Hachemanne S, Blanc P, Domergue J, et al. Liver resection or transplantation for hepatocellular carcinoma? Retrospective analysis of 215 patients with cirrhosis. J Hepatol 1997;26:1274-1280.
53. Sarasin FP, Giostra E, Mentha G, Hadengue A, Parial hepatectomy or orthoopic liver transplant for the treatment of respectable hepatocellular carcinoma? A cost-effectiveness perspective. Hepatology 1998;28:436-442.
54. Otto G, Heuschen U, Hofmann WJ, Krumm G, Hinz U, Herfarth C. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma. A retrospective analysis. Ann Surg 1998;227:424-432.
55. Pichlmayr R, Weimann A, Steinhoff G, Ringe B. Liver transplantation for hepatocellular carcinoma: clinical results and future aspects. Cancer Chemoter Pharmacol 1992;31:S157-S161.
56. Yamamoto J, Iwatsuki S, Kosuge T, Dvorchik I, Shimada K, Marsh JW, et al. Should hepatomas be treated with hepatic resection or transplantation? Cancer 1999;86:1151-1158.
57. Llovet JM, Bruix J, Gores GJ. Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy. Hepatology 2000;31:1019-1021.
58. Majno PE, Adam R, Mazzaferro V, Regalia E, Mentha G, Bismuth H, et al. Liver transplantation for recurrence after resection of solitary hepatocellular carcinoma. Transplantation 1999;67:579.
59. Poon RTP, Fan ST, Lo CM, Liu CL, Wong J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function. Implications for a strategy of salvage transplantation. Ann Surg 2002;3:373-382.
60. Adam R, Azoulay D, Castaing D, Eshkenazy R, Pascal G, Hashizume K, et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg 2003;238:508-519.
61. Majno P, Sarasin F, Mentha G, Hadengue A. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome oriented decision analysis. Hepatology 2000;31:899-906.
62. Strong RW. Whither living donor liver transplantation? Liver Transpl Surg 1999;5:536-538.
63. Miller CM, Gondolesi GE, Florman S, Matsumoto C, Muoz L, Yoshizumi T, et al. One hundred nine living donor liver transplants in adults and children: a single-centre experience. Ann Surg 2001;234:301-311.
64. Sarasin FP, Majno P, Llovet JM, Mentha J, Bruix J, Hadengue A. Living donor liver transplantation for early hepatocellular carcinoma: a life expectancy and cost-effectiveness perspective. Hepatology 2001;33:1073-1079.
65. Neuberger J. Liver transplantation. J Hepatol 2000;32(Suppl. 1):198-207.
66. Houben KW, McCall JL. Liver transplantation for hepatocellular carcinoma in patients without underlying disease. A systematic review. Liver Transpl Surg 1999;5:91-95.
67. Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 1991;110:726-735.